Prof Geoffrey Lindeman

Related Grants and Projects

• Participant in Apoptosis and Stem/Progenitor Cells in the Development and Treatment of Cancer (funded by National Health and Medical Research Council)
• Principal investigator of BRCA-P: An international randomised phase III study evaluating the RANK ligand inhibitor denosumab for the prevention of breast cancer in BRCA1 mutation carriers (funded by National Health and Medical Research Council)
• Principal investigator of Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic (funded by National Health and Medical Research Council)
• Principal investigator of Research Fellowship (funded by National Health and Medical Research Council)